i
iOmx is a young, dynamic start-up in the field of immuno-oncology located in Martinsried/Munich, Germany. Backed by a powerful technology platform and internationally renowned investors, iOmx is driving forward a cutting-edge portfolio of early-stage novel immune-checkpoint drugs through pre-clinical and clinical development. Imprint: https://iomx.com/imprint
Investor insights
Funding rounds participated in
$75M sweet spot round size
Investor type
Privately Held
Basic info
Industry
Pharmaceutical Manufacturing
Sectors
Pharmaceutical Manufacturing
Date founded
2016
Funding rounds raised
Total raised
$75M
from 2 investors over 1 rounds
i
iOmx Therapeutics AG raised $75M on November 5, 2021
Investors: MIG Capital and + 2 Other investors